USD 0.35
(-0.14%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.03 Million USD | -18.4% |
2022 | 3.71 Million USD | -72.58% |
2021 | 13.56 Million USD | 17.46% |
2020 | 11.55 Million USD | 2551.97% |
2019 | 435.54 Thousand USD | -71.98% |
2018 | 1.55 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 3.21 Million USD | -11.04% |
2024 Q2 | 2.39 Million USD | -11.44% |
2023 FY | 3.03 Million USD | -18.4% |
2023 Q1 | 3.92 Million USD | 5.57% |
2023 Q4 | 3.03 Million USD | -25.06% |
2023 Q2 | 3.51 Million USD | -10.43% |
2023 Q3 | 4.05 Million USD | 15.15% |
2022 Q3 | 2 Million USD | -11.27% |
2022 FY | 3.71 Million USD | -72.58% |
2022 Q1 | 7.81 Million USD | -42.36% |
2022 Q2 | 2.26 Million USD | -71.08% |
2022 Q4 | 3.71 Million USD | 85.35% |
2021 Q1 | 11.06 Million USD | -4.22% |
2021 FY | 13.56 Million USD | 17.46% |
2021 Q2 | 11.21 Million USD | 1.39% |
2021 Q3 | 3.94 Million USD | -64.85% |
2021 Q4 | 13.56 Million USD | 244.09% |
2020 Q1 | 402.99 Thousand USD | -7.47% |
2020 FY | 11.55 Million USD | 2551.97% |
2020 Q2 | 426.89 Thousand USD | 5.93% |
2020 Q3 | 462.12 Thousand USD | 8.25% |
2020 Q4 | 11.55 Million USD | 2399.47% |
2019 Q4 | 435.54 Thousand USD | 38.58% |
2019 FY | 435.54 Thousand USD | -71.98% |
2019 Q1 | 383.68 Thousand USD | -75.32% |
2019 Q2 | 349.47 Thousand USD | -8.92% |
2019 Q3 | 314.29 Thousand USD | -10.07% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | 1.55 Million USD | 0.0% |
2018 Q3 | 1.55 Million USD | 0.0% |
2018 Q2 | 1.55 Million USD | 0.0% |
2018 FY | 1.55 Million USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | -100.0% |
2015 Q3 | 50 Thousand USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | -100.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | 15.87 Thousand USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | 15.87 Thousand USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Safety Shot Inc | 304.9 Thousand USD | -895.497% |
Bright Green Corporation | 201.78 Thousand USD | -1404.26% |
Embecta Corp. | 1.62 Billion USD | 99.813% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.02% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 96.667% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.38% |
Dynavax Technologies Corporation | 252.41 Million USD | 98.797% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 99.395% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | 77.222% |
Pacira BioSciences, Inc. | 513.79 Million USD | 99.409% |
PainReform Ltd. | 30 Thousand USD | -10017.803% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -463.106% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -463.106% |
SCYNEXIS, Inc. | 12.15 Million USD | 75.036% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -2491.451% |
Journey Medical Corporation | 14.62 Million USD | 79.241% |
Alpha Teknova, Inc. | 13.25 Million USD | 77.093% |
Procaps Group, S.A. | 28.41 Million USD | 89.316% |
Theratechnologies Inc. | 51.26 Million USD | 94.079% |
Harrow Health, Inc. | 183.17 Million USD | 98.343% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -3388.898% |
Biofrontera Inc. | 804 Thousand USD | -277.53% |
DURECT Corporation | 2.7 Million USD | -12.337% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 90.856% |
Cronos Group Inc. | 1.55 Million USD | -94.698% |
OptiNose, Inc. | 611 Thousand USD | -396.782% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.391% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 91.122% |
RedHill Biopharma Ltd. | 455 Thousand USD | -567.108% |
Organogenesis Holdings Inc. | 60.74 Million USD | 95.003% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 76.257% |
Radius Health, Inc. | 339.66 Million USD | 99.106% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | 70.41% |
Phibro Animal Health Corporation | 458.28 Million USD | 99.338% |
Procaps Group S.A. | 28.41 Million USD | 89.316% |
Alvotech | 1.02 Billion USD | 99.705% |
TherapeuticsMD, Inc. | 6.53 Million USD | 53.531% |
Viatris Inc. | 16.18 Billion USD | 99.981% |
Rockwell Medical, Inc. | 8.29 Million USD | 63.399% |
Aytu BioPharma, Inc. | 10.87 Million USD | 72.094% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -803.399% |
Tilray Brands, Inc. | 287.93 Million USD | 98.946% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 97.481% |
Shineco, Inc. | 10.01 Million USD | 69.699% |
PetIQ, Inc. | 437.82 Million USD | 99.307% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -1345.4% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 98.825% |
Alimera Sciences, Inc. | 64.48 Million USD | 95.293% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | 92.119% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -2146.919% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | 55.736% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -321.575% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -13400.004% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 90.735% |
Hempacco Co., Inc. | 5.93 Million USD | 48.822% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 99.705% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 94.601% |
Lantheus Holdings, Inc. | 616.12 Million USD | 99.507% |
Currenc Group, Inc. | 2.5 Million USD | -21.076% |
Kamada Ltd. | 7.43 Million USD | 59.191% |
Indivior PLC | 235.66 Million USD | 98.712% |
Evoke Pharma, Inc. | 5 Million USD | 39.293% |
Flora Growth Corp. | 942 Thousand USD | -222.223% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -13400.004% |
Evolus, Inc. | 120.35 Million USD | 97.478% |
HUTCHMED (China) Limited | 48.18 Million USD | 93.701% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.485% |
Akanda Corp. | 2.49 Million USD | -21.552% |